AI assistant
Sending…
GENETIC TECHNOLOGIES LIMITED — Director's Dealing 2004
Jan 4, 2004
65022_rns_2004-01-04_0056fa3d-fb9d-4efe-ae15-e3db076d8192.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y
Rule 3.19A.2
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/9/2001.
| Name of entity Genetic Technologies Limited | |
|---|---|
| ABN 17 009 212 328 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr Mervyn Jacobson |
|---|---|
| Date of last notice | 24 December 2003 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Direct or indirect interest | Direct and indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Dr Mervyn Jacobson controls JGT Aps (49,000,000) and Mervyn Jacobson Aps (49,000,000) |
| Date of change | $22 - 30$ December 2003 |
| No. of securities held prior to change | $49,000,000 - JGT$ Aps 49,000,000 - Mervyn Jacobson Aps $3,072,600 - Direct$ |
| Class | Fully paid ordinary shares |
| Number acquired | 82,522 |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
\$37,405 |
| No. of securities held after change | $49,000,000 - JGT$ Aps 49,000,000 - Mervyn Jacobson Aps $3,155,122 - Direct$ |
+ See chapter 19 for defined terms.
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
On-market purchases |
|---|---|
Part 2 - Change of director's interests in contracts
| Detail of contract | |
|---|---|
| Nature of interest | |
| Name of registered holder | |
| (if issued securities) | |
| Date of change | |
| No, and class of securities to which interest | |
| related prior to change | |
| Note: Details are only required for a contract in relation to which the interest has changed |
|
| Interest acquired | |
| Interest disposed | |
| Value/Consideration | |
| Note: If consideration is non-cash, provide details and an estimated valuation |
|
| Interest after change |
Dated at Sydney on 5 January 2004
+ See chapter 19 for defined terms.
More from GENETIC TECHNOLOGIES LIMITED
Interim / Quarterly Report
2026
Mar 29
Interim / Quarterly Report
2026
Mar 29
Interim / Quarterly Report
2026
Mar 29
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Board/Management Information
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 5